InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Altmeyer Anne. Officer active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 6 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €28k. Activity tracked since 30 May 2024. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Altmeyer Anne is a Director of Corbus Pharmaceuticals Holdings, Inc. (XNAS). She has 6 filings in total, and across the sampled recent filings from 2024-06-03 to 2026-06-11, sales total 27534 EUR, with the modal transaction nature listed as sale.